Healthcare provider profile · identity verified

Rabia Alvi, MD

Family Practice · OAK LAWN, IL · NPI 1740784685

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	699	254
Amlodipine Besylate	Amlodipine Besylate	352	119
Metformin Hcl	Metformin Hcl	325	115
Tizanidine Hcl	Tizanidine Hcl	281	121
Diclofenac Sodium	Diclofenac Sodium	280	174
Furosemide	Furosemide	239	105
Losartan Potassium	Losartan Potassium	230	82
Lisinopril	Lisinopril	222	76
Metoprolol Succinate	Metoprolol Succinate	217	74
Gabapentin	Gabapentin	216	81
Pantoprazole Sodium	Pantoprazole Sodium	212	78
Albuterol Sulfate Hfa	Albuterol Sulfate	208	70
Hydrochlorothiazide	Hydrochlorothiazide	204	64
Omeprazole	Omeprazole	181	76
Fluticasone Propionate	Fluticasone Propionate	169	107
Glipizide	Glipizide	161	57
Rosuvastatin Calcium	Rosuvastatin Calcium	158	58
Levothyroxine Sodium	Levothyroxine Sodium	125	42
Tamsulosin Hcl	Tamsulosin Hcl	115	43
Eliquis	Apixaban	106	30
Alendronate Sodium	Alendronate Sodium	105	33
Jardiance	Empagliflozin	102	32
Carvedilol	Carvedilol	90	33
Warfarin Sodium	Warfarin Sodium	86	18
Metoprolol Tartrate	Metoprolol Tartrate	85	31
Simvastatin	Simvastatin	81	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	21
Triamcinolone Acetonide	Triamcinolone Acetonide	74	43
Allopurinol	Allopurinol	71	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	33
Sertraline Hcl	Sertraline Hcl	70	26
Meclizine Hcl	Meclizine Hcl	69	31
Vitamin D2	Ergocalciferol (Vitamin D2)	64	31
Alprazolam	Alprazolam	62	19
Nifedipine Er	Nifedipine	62	19
Azithromycin	Azithromycin	59	50
Potassium Chloride	Potassium Chloride	57	19
Doxycycline Monohydrate	Doxycycline Monohydrate	56	40
Ibuprofen	Ibuprofen	54	23
Tramadol Hcl	Tramadol Hcl	49	14
Donepezil Hcl	Donepezil Hcl	48	20
Oxybutynin Chloride Er	Oxybutynin Chloride	48	23
Enalapril Maleate	Enalapril Maleate	46	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	16
Metformin Hcl Er	Metformin Hcl	46	19
Famotidine	Famotidine	43	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	17
Finasteride	Finasteride	41	12
Meloxicam	Meloxicam	41	14
Duloxetine Hcl	Duloxetine Hcl	40	12
Januvia	Sitagliptin Phosphate	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	31
Ozempic	Semaglutide	39	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	27
Spironolactone	Spironolactone	37	13
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	12
Xarelto	Rivaroxaban	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Mirtazapine	Mirtazapine	31	15
Novolog Flexpen	Insulin Aspart	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	14
Clopidogrel	Clopidogrel Bisulfate	29	13
Glimepiride	Glimepiride	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	14
Fenofibrate	Fenofibrate	24	suppressed
Baclofen	Baclofen	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Clotrimazole	Clotrimazole	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Ibu	Ibuprofen	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Naproxen	Naproxen	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Prednisone	Prednisone	12	12
Teriflunomide	Teriflunomide	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error